Delphia (Usa) Inc. Viatris Inc Transaction History

Delphia (Usa) Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$9.02 - $10.29 $10,517 - $11,998	-1,166 Reduced 5.85%	18,766 $187,000
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $1,913 - $2,550	208 Added 1.05%	19,932 $191,000
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $59,479 - $78,850	-6,821 Reduced 25.7%	19,724 $219,000
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $225,101 - $295,445	26,545 New	26,545 $226,000
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $310,300 - $382,652	-31,186 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $107,821 - $169,261	10,991 Added 54.42%	31,186 $339,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $244,157 - $296,462	20,195 New	20,195 $273,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.